Australia markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
25.86-0.48 (-1.82%)
At close: 04:02PM EDT
25.91 +0.05 (+0.19%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 146.43B
Enterprise value 204.59B
Trailing P/E 69.89
Forward P/E 11.67
PEG ratio (5-yr expected) 0.26
Price/sales (ttm)2.49
Price/book (mrq)1.65
Enterprise value/revenue 3.50
Enterprise value/EBITDA 21.41

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-37.20%
S&P500 52-week change 323.42%
52-week high 341.33
52-week low 325.61
50-day moving average 327.26
200-day moving average 331.01

Share statistics

Avg vol (3-month) 343.12M
Avg vol (10-day) 336.76M
Shares outstanding 55.66B
Implied shares outstanding 65.77B
Float 85.64B
% held by insiders 10.05%
% held by institutions 169.93%
Shares short (28 Mar 2024) 465M
Short ratio (28 Mar 2024) 41.4
Short % of float (28 Mar 2024) 41.15%
Short % of shares outstanding (28 Mar 2024) 41.15%
Shares short (prior month 29 Feb 2024) 466.12M

Dividends & splits

Forward annual dividend rate 41.68
Forward annual dividend yield 46.50%
Trailing annual dividend rate 31.64
Trailing annual dividend yield 36.23%
5-year average dividend yield 43.97
Payout ratio 4443.24%
Dividend date 301 Mar 2024
Ex-dividend date 425 Jan 2024
Last split factor 21054:1000
Last split date 317 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 3.62%
Operating margin (ttm)-49.97%

Management effectiveness

Return on assets (ttm)1.55%
Return on equity (ttm)2.35%

Income statement

Revenue (ttm)58.5B
Revenue per share (ttm)10.37
Quarterly revenue growth (yoy)-41.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)2.13B
Diluted EPS (ttm)0.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.69B
Total cash per share (mrq)2.25
Total debt (mrq)75.33B
Total debt/equity (mrq)84.37%
Current ratio (mrq)0.91
Book value per share (mrq)15.77

Cash flow statement

Operating cash flow (ttm)8.7B
Levered free cash flow (ttm)1.02B